melatonin has been researched along with Panic Disorder in 8 studies
Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of pentagastrin, a synthetic analogue of the cholecystokinin tetrapeptide (CCK4), were studied in 15 patients with panic disorder and 15 healthy controls." | 9.07 | Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. ( den Boer, JA; Haigh, JR; Traub, M; van Megen, HJ; Westenberg, HG, 1994) |
| "Nocturnal urinary cortisol, norepinephrine, epinephrine, testosterone, and melatonin secretion patterns were studied in male patients with DSM IV/ICD-10 panic disorder (n = 16) over two series of 5 consecutive nights each." | 7.69 | Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorder. ( Bandelow, B; Broocks, A; Hajak, G; Huether, G; Pilz, J; Rüther, E; Sengos, G; Wedekind, D, 1997) |
| "The effects of pentagastrin, a synthetic analogue of the cholecystokinin tetrapeptide (CCK4), were studied in 15 patients with panic disorder and 15 healthy controls." | 5.07 | Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. ( den Boer, JA; Haigh, JR; Traub, M; van Megen, HJ; Westenberg, HG, 1994) |
| "Nocturnal urinary cortisol, norepinephrine, epinephrine, testosterone, and melatonin secretion patterns were studied in male patients with DSM IV/ICD-10 panic disorder (n = 16) over two series of 5 consecutive nights each." | 3.69 | Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorder. ( Bandelow, B; Broocks, A; Hajak, G; Huether, G; Pilz, J; Rüther, E; Sengos, G; Wedekind, D, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zapp, AA | 1 |
| Fischer, EC | 1 |
| Deuschle, M | 1 |
| Kinrys, G | 1 |
| Coleman, E | 1 |
| Rothstein, E | 1 |
| Servant, D | 1 |
| van Megen, HJ | 1 |
| Westenberg, HG | 1 |
| den Boer, JA | 1 |
| Haigh, JR | 1 |
| Traub, M | 1 |
| Bandelow, B | 1 |
| Sengos, G | 2 |
| Wedekind, D | 2 |
| Huether, G | 2 |
| Pilz, J | 1 |
| Broocks, A | 1 |
| Hajak, G | 2 |
| Rüther, E | 1 |
| Rodenbeck, A | 1 |
| Ehrenthal, HD | 1 |
| Leonard, S | 1 |
| Zhou, D | 1 |
| Smirne, S | 1 |
| Ferini-Strambi, L | 1 |
| Sandyk, R | 1 |
| Dann, LC | 1 |
2 reviews available for melatonin and Panic Disorder
| Article | Year |
|---|---|
Natural remedies for anxiety disorders: potential use and clinical applications.
Topics: Anti-Anxiety Agents; Antioxidants; Anxiety Disorders; Humans; Hypericum; Inositol; Kava; Melatonin; | 2009 |
[Biological rhythms and anxiety disorders].
Topics: Anxiety Disorders; Circadian Rhythm; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Melaton | 2006 |
3 trials available for melatonin and Panic Disorder
| Article | Year |
|---|---|
Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
Topics: Adult; beta-Endorphin; Cholecystokinin; Dose-Response Relationship, Drug; Double-Blind Method; Femal | 1994 |
No evidence for a physiological coupling between melatonin and glucocorticoids.
Topics: Adult; Animals; Cell Division; Circadian Rhythm; Dexamethasone; Glucocorticoids; Hormones; Humans; L | 1997 |
Clinical applications of cyclic alternating pattern.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anticonvulsants; Electroencephalography; GABA Modulators; | 1999 |
3 other studies available for melatonin and Panic Disorder
| Article | Year |
|---|---|
The effect of agomelatine and melatonin on sleep-related eating: a case report.
Topics: Acetamides; Central Nervous System Depressants; Depressive Disorder, Major; Female; Humans; Melatoni | 2017 |
Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorder.
Topics: Adult; Agoraphobia; Humans; Hydrocortisone; Longitudinal Studies; Male; Melatonin; Norepinephrine; P | 1997 |
Seasonal panic disorder: a possible variant of seasonal affective disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Combined Modality Therapy; Depressive Disord | 1992 |